Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Active, not recruiting Not applicable

TED Stocking vs. Reparel Garment After Hip Replacement

NCT07246200 · tracked via the Priya Life Science USA tracker
Sponsor
Reparel
Phase
Not applicable
Started
2022-01-01
Last updated
2025-11-24

Condition(s) studied

Osteoarthritis (OA) of the Hip

Investigational drug(s) / intervention(s)

Reparel Bioactive SleeveTED Stocking

Reparel Bioactive Sleeve: A non-compressive, photobiomodulating sleeve worn on the leg to reduce postoperative pain and swelling.

TED Stocking: Standard-of-care gradient compression stocking used after hip replacement.

Study summary

This randomized, prospective study compares the effectiveness of a novel bioactive garment (Reparel Leg Sleeve) versus standard TED compression stockings in reducing postoperative leg swelling, pain, and deep vein thrombosis (DVT) rates following total hip arthroplasty. The study aims to determine whether the bioactive garment improves patient comfort and recovery outcomes compared to traditional stockings.

Eligibility

Sex
ALL
Min age
18 Years
Max age
89 Years
Healthy volunteers
No
Inclusion Criteria: * Age 18-89 * Undergoing primary unilateral total hip replacement * BMI \< 40 * Able to follow postoperative protocol * English speaking Exclusion Criteria: * Age \<18 or \>90 * Physical inability to use stockings * Allergy to silicone/polyester * Active DVT * History of vascular bypass on operative limb (e.g., Fem-Pop, Fem-Fem) * Inability to comply with post-op/rehab * Lymphedema

Primary outcome measure(s)

  • Pain Score (VAS) — Postoperative Weeks 2, 6, and 12
    Pain will be measured using the Visual Analog Scale (VAS), a standard 0-10 numeric rating scale. Patients will report pain levels during routine postoperative follow-up visits or via validated questionnaires.
  • HOOS Jr. Score — Postoperative Weeks 6 and 12
    The Hip Disability and Osteoarthritis Outcome Score, Junior (HOOS Jr.) evaluates hip function and patient-reported symptoms following total hip arthroplasty.
  • VR-12 Score — Postoperative Week 12
    The Veterans RAND 12-Item Health Survey (VR-12) evaluates patient-reported physical and mental health status.
  • HSS Satisfaction Score — Postoperative Week 12
    The Hospital for Special Surgery (HSS) Satisfaction Score assesses patient satisfaction following hip replacement surgery.
  • Forgotten Joint Score — Postoperative Week 12
    The Forgotten Joint Score measures the extent to which patients are aware of their hip joint during daily activities, reflecting functional recovery.

Trial sites (1)

FacilityCityRegionStatus
Institute for Joint Restoration Fremont California

Other trials for the same condition

MDR Vivacit-E Elevated Study Enrolling by invitation
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07246200 on ClinicalTrials.gov ↗ ← All trials in the USA